Paul J. Hastings's most recent trade in Nkarta Inc was a trade of 1,790 Common Stock done at an average price of $1.8 . Disclosure was reported to the exchange on June 18, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Nkarta Inc | Paul J. Hastings | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 1.79 per share. | 18 Jun 2025 | 1,790 | 320,069 | - | 1.8 | 3,204 | Common Stock |
| enGene Holdings Inc | Paul J. Hastings | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2025 | 22,500 | 22,500 | - | - | Stock Option (Right to Buy) | |
| Nkarta Inc | Paul J. Hastings | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 377,000 | 377,000 | - | - | Stock Option (right to buy) | |
| Nkarta Inc | Paul J. Hastings | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 2.20 per share. | 15 Jan 2025 | 17,378 | 319,859 | - | 2.2 | 38,232 | Common Stock |
| Nkarta Inc | Paul J. Hastings | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 565,500 | 565,500 | - | - | Stock Option (right to buy) | |
| Nkarta Inc | Paul J. Hastings | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 94,500 | 337,237 | - | 0 | Common Stock | |
| Nkarta Inc | Paul J. Hastings | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 5.60 per share. | 18 Jun 2024 | 1,770 | 240,737 | - | 5.6 | 9,912 | Common Stock |
| enGene Holdings Inc | Paul J. Hastings | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2024 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Pacira BioSciences Inc | Paul J. Hastings | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 12,179 | 12,179 | - | - | Stock Option (Right to Buy) | |
| Pacira BioSciences Inc | Paul J. Hastings | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 5,230 | 13,604 (0%) | 0% | 0 | Common Stock | |
| Pacira BioSciences Inc | Paul J. Hastings | Director | Sale of securities on an exchange or to another person at price $ 28.38 per share. | 12 Jun 2024 | 880 | 12,724 (0%) | 0% | 28.4 | 24,974 | Common Stock |
| Nkarta Inc | Paul J. Hastings | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 13.33 per share. | 01 Mar 2024 | 137,642 | 240,507 | - | 13.3 | 1,834,768 | Common Stock |
| Nkarta Inc | Paul J. Hastings | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 13.00 per share. | 01 Mar 2024 | 12,358 | 378,149 | - | 13 | 160,654 | Common Stock |
| Nkarta Inc | J. Hastings Paul | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 8.74 per share. | 16 Jan 2024 | 9,697 | 390,507 | - | 8.7 | 84,752 | Common Stock |
| Nkarta Inc | Paul J. Hastings | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2024 | 509,500 | 509,500 | - | - | Stock Option (right to buy) | |
| Nkarta Inc | Hastings J. Paul | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2024 | 85,000 | 400,204 | - | 0 | Common Stock | |
| Nkarta Inc | Paul J. Hastings | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 4.85 per share. | 20 Jun 2023 | 1,704 | 313,402 | - | 4.8 | 8,264 | Common Stock |
| Pacira BioSciences Inc | Paul J. Hastings | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 12,925 | 12,925 | - | - | Stock Option (Right to Buy) | |
| Pacira BioSciences Inc | Paul J. Hastings | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 1,775 | 8,374 (0%) | 0% | 0 | Common Stock | |
| Pacira BioSciences Inc | Paul J. Hastings | Director | Sale of securities on an exchange or to another person at price $ 38.34 per share. | 05 Jun 2023 | 580 | 6,599 (0%) | 0% | 38.3 | 22,237 | Common Stock |
| Pacira BioSciences Inc | Paul J. Hastings | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2023 | 7,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Pacira BioSciences Inc | Paul J. Hastings | Director | Sale of securities on an exchange or to another person at price $ 41.85 per share. | 15 May 2023 | 7,000 | 7,179 (0%) | 0% | 41.9 | 292,950 | Common Stock |
| Pacira BioSciences Inc | Paul J. Hastings | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 29.90 per share. | 15 May 2023 | 7,000 | 14,179 (0%) | 0% | 29.9 | 209,300 | Common Stock |
| Nkarta Inc | Paul J. Hastings | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jan 2023 | 386,500 | 386,500 | - | - | Stock Option (right to buy) | |
| Nkarta Inc | Paul J. Hastings | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jan 2023 | 64,500 | 316,797 | - | 0 | Common Stock | |
| Nkarta Inc | Paul J. Hastings | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 5.49 per share. | 13 Jan 2023 | 3,691 | 313,106 | - | 5.5 | 20,264 | Common Stock |
| Nkarta Inc | Paul J. Hastings | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 13.01 per share. | 21 Sep 2022 | 6,126 | 274,335 | - | 13.0 | 79,717 | Common Stock |
| Pacira BioSciences Inc | Paul J. Hastings | Director | Sale of securities on an exchange or to another person at price $ 56.95 per share. | 11 Jul 2022 | 533 | 7,179 (0%) | 0% | 56.9 | 30,354 | Common Stock |
| Nkarta Inc | Paul J. Hastings | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2022 | 120,000 | 120,000 | - | - | Stock Option (right to buy) | |
| Nkarta Inc | Paul J. Hastings | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2022 | 19,500 | 280,461 | - | 0 | Common Stock | |
| Pacira BioSciences Inc | Paul J. Hastings | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 8,225 | 8,225 | - | - | Stock Option (Right to Buy) | |
| Pacira BioSciences Inc | Paul J. Hastings | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 1,160 | 7,712 (0%) | 0% | 0 | Common Stock | |
| Nkarta Inc | Paul J. Hastings | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2022 | 251,100 | 251,100 | - | - | Stock Option (right to buy) | |
| Nkarta Inc | Paul J. Hastings | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2022 | 41,900 | 260,961 | - | 0 | Common Stock | |
| Nkarta Inc | Paul J. Hastings | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 26.39 per share. | 21 Jun 2021 | 4,693 | 231,368 | - | 26.4 | 123,848 | Common Stock |
| Nkarta Inc | Paul J. Hastings | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 26.89 per share. | 21 Jun 2021 | 3,807 | 227,561 | - | 26.9 | 102,370 | Common Stock |
| Pacira BioSciences Inc | Paul J. Hastings | Director | Sale of securities on an exchange or to another person at price $ 62.19 per share. | 04 Jun 2021 | 630 | 5,486 (0%) | 0% | 62.2 | 39,180 | Common Stock |
| Nkarta Inc | Paul J. Hastings | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 30.23 per share. | 30 Mar 2021 | 11,461 | 241,600 | - | 30.2 | 346,466 | Common Stock |
| Nkarta Inc | Paul J. Hastings | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 32.21 per share. | 30 Mar 2021 | 3,130 | 236,061 | - | 32.2 | 100,817 | Common Stock |
| Nkarta Inc | Paul J. Hastings | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 31.24 per share. | 30 Mar 2021 | 2,409 | 239,191 | - | 31.2 | 75,257 | Common Stock |
| Pacira BioSciences Inc | Paul J. Hastings | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Mar 2021 | 3,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Pacira BioSciences Inc | Paul J. Hastings | Director | Sale of securities on an exchange or to another person at price $ 65.88 per share. | 05 Mar 2021 | 3,000 | 6,116 (0%) | 0% | 65.9 | 197,640 | Common Stock |
| Pacira BioSciences Inc | Paul J. Hastings | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.98 per share. | 05 Mar 2021 | 3,000 | 9,116 (0%) | 0% | 14.0 | 41,940 | Common Stock |
| Nkarta Inc | Paul J. Hastings | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jan 2021 | 157,500 | 157,500 | - | - | Stock Option (right to buy) |